Article Page

Abstract

We investigate the teleportation between two relatively accelerating partners undergoing the phase flip, bit flip and bit-phase flip channels. We find that: 1) the fidelity decreases by increasing the acceleration of accelerated observer; 2) the dynamic evolution of the fidelity is different for various channels if the acceleration is fixed; and 3) the fidelity is always symmetric about 212 where  is a parameter of the Quantum Teleportation transmission state with an Accelerated of a large scale chemical data mining drug discovery relative exploration for a descriptor-based encoding of selected hits atom types to a multi-covalent fragment-based pharmaco-ligand against novel elucidated active β-amyloid Peptide binding sites.

Keywords

Quantum Teleportation; Non-Inertial Frames; Open System 1. Quantum Teleportation Accelerated;large scale; chemical data mining; drug discovery; relative exploration; descriptor-based; encoding; selected hits; atom types; multi-covalent; fragment-based; pharmaco-ligand; novel elucidated; active β-amyloid Peptide; binding sites;

Article Type

Research Article – Abstract

Publication history

Received: Sep 20, 2017
Accepted: Sep 25, 2017
Published: Oct 01, 2017

Citation

Grigoriadis Ioannis, Grigoriadis George, Grigoriadis Nikolaos, George Galazios (2017) Quantum Teleportation with an Accelerated of a large scale chemical data mining drug discovery relative exploration for a descriptor-based encoding of selected hits atom types to a multi-covalent fragment-based pharmaco-ligand against novel elucidated active β-amyloid Peptide binding sites.

Authors Info

Grigoriadis Nikolaos
Department of IT Computer Aided Personalized Myoncotherapy, Cartigenea-Cardiogenea, Neurogenea-Cellgenea, Cordigenea-HyperoligandorolTM,
Biogenea Pharmaceuticals Ltd,
Thessaloniki, Greece;

Grigoriadis Ioannis
Department of Computer Drug Discovery Science, BiogenetoligandorolTM,
Biogenea Pharmaceuticals Ltd,
Thessaloniki, Greece;

Grigoriadis George
Department of Stem Cell Bank and ViroGeneaTM,
Biogenea Pharmaceuticals Ltd,
Thessaloniki, Greece;

George Galazios
Professor of Obstetrics and Gynecology,
Democritus University of Thrace,
Komotini, Greece;

E-mail: biogeneadrug@gmail.com

File not available